MNZO OTC
Manzo Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.0%
5Y: -66.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2K
+267.5% ▲
3Y CAGR: -91.2%
Gross Profit
$793
+44.7% ▲
3Y CAGR: -89.8%
Operating Income
$793
+100.3% ▲
Net Income
-$36K
+96.3% ▲
EPS (Diluted)
$-0.00
+98.9% ▲
EBITDA
$793
+100.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2003 | FY2004 | FY2014 | FY2015 |
|---|---|---|---|---|
| Revenue | $3M | $3M | $548 | $2K |
| YoY Growth | +0.0% | +2.2% | +0.0% | +267.5% |
| Cost of Revenue | $2M | $3M | $0 | $1K |
| Gross Profit | $756K | $21K | $548 | $793 |
| Gross Margin | 25.2% | 0.7% | 100.0% | 39.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3M | $3M | $246K | $0 |
| Operating Expenses | $4M | $3M | $246K | $0 |
| Operating Income | -$3M | -$3M | -$246K | $793 |
| Operating Margin | -108.1% | -104.2% | -44856.4% | 39.4% |
| Interest Expense | $803K | $914K | $540K | $36K |
| Income Before Tax | $0 | $0 | -$989K | -$36K |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4M | -$4M | -$989K | -$36K |
| Net Margin | -131.6% | -135.2% | -180493.8% | -1799.6% |
| EPS (Diluted) | $-1.20 | $-1.20 | $-0.00 | $-0.00 |
| EBITDA | -$2M | -$3M | -$449K | $793 |
| Shares Outstanding | 3M | 3M | 340M | 1.16B |